FIELD: medicine.
SUBSTANCE: invention relates to medicine, namely, to anticancer therapy, and can be used to treat SW620 human colon cancer in an experiment on immunodeficient mice. For this, an indolocarbazole derivative is used 6-amino-12-(α-L-arabinopyranosyl)indalo[2,3-a]pyrrolo[3,4-c]carbazole-5,7-dione, which is administrated in total doses of 12.5–150 mg/kg.
EFFECT: invention provides the cancer treatment in immunodeficient mice in the experiment.
1 cl, 3 tbl, 3 dwg, 3 ex
| Title | Year | Author | Number |
|---|---|---|---|
| METHOD OF TREATING COLON CANCER | 2012 |
|
RU2529831C2 |
| ANTI-CANCER DRUG TOPOISOMERASE I INHIBITOR | 2022 |
|
RU2786727C1 |
| METHOD OF LUNG CANCER TREATMENT | 2008 |
|
RU2365370C1 |
| LUNG CANCER THERAPY | 2008 |
|
RU2367436C1 |
| METHOD OF TREATING LUNG CANCER | 2009 |
|
RU2414894C1 |
| DERIVATIVE OF THE CLASS OF N-GLYCOSIDES INDOLO[2,3-A]PYRROLO[3,4-C]CARBAZOLE-5,7-DIONE - N-{12-(β-D-XYLOPYRANOSYL)-5,7-DIOXO-INDOLO[2,3-A]PYRROLO[3,4-C]CARBAZOL-6-YL} PYRIDINE-2-CARBOXAMIDE, WHICH HAS CYTOTOXIC AND ANTITUMOR ACTIVITY | 2017 |
|
RU2667906C1 |
| METHOD OF PRODUCTION OF SUBDERMAL XENOGRAFTS OF CELL LINE OF PEOPLE SKIN MELANOMA mel Cher WITH MUTATION V600E BRAF FOR PRECLINICAL STUDY OF ANTINEOPLASTIC TARGETED AGENTS | 2014 |
|
RU2572569C1 |
| N-GLYCOSIDES OF INDOLO[2,3-a]PYRROLO[3,4-c]CARBAZOLES HAVING ANTITUMOUR ACTIVITY | 2014 |
|
RU2548045C1 |
| METHOD FOR OBTAINING AN ORTHOTOPIC PDX MODEL OF SQUAMOUS CELL CARCINOMA OF THE HUMAN ESOPHAGUS FOR THE STUDY OF RADIATION THERAPY IN AN EXPERIMENT | 2021 |
|
RU2760084C1 |
| SUBDERMAL XENOGRAFTS OF CELL LINE OF AMELANOTIC HUMAN SKIN MELANOMA MEL RAC WITH MUTATION NRAS FOR PRECLINICAL STUDY OF ANTINEOPLASTIC TARGETED AGENTS | 2016 |
|
RU2651939C2 |
